Orthopediatrics (KIDS) Loans and Notes Receivables (2018 - 2021)
Orthopediatrics (KIDS) has disclosed Loans and Notes Receivables for 4 consecutive years, with $59000.0 as the latest value for Q3 2021.
- On a quarterly basis, Loans and Notes Receivables fell 87.61% to $59000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $59000.0, a 87.61% decrease, with the full-year FY2020 number at $337000.0, down 40.25% from a year prior.
- Loans and Notes Receivables was $59000.0 for Q3 2021 at Orthopediatrics, down from $95000.0 in the prior quarter.
- In the past five years, Loans and Notes Receivables ranged from a high of $656000.0 in Q2 2020 to a low of $59000.0 in Q3 2021.
- A 4-year average of $430166.7 and a median of $505000.0 in 2018 define the central range for Loans and Notes Receivables.
- Peak YoY movement for Loans and Notes Receivables: increased 27.38% in 2020, then tumbled 87.61% in 2021.
- Orthopediatrics' Loans and Notes Receivables stood at $502000.0 in 2018, then grew by 12.35% to $564000.0 in 2019, then plummeted by 40.25% to $337000.0 in 2020, then crashed by 82.49% to $59000.0 in 2021.
- Per Business Quant, the three most recent readings for KIDS's Loans and Notes Receivables are $59000.0 (Q3 2021), $95000.0 (Q2 2021), and $323000.0 (Q1 2021).